1. Home
  2. ARDX vs NFE Comparison

ARDX vs NFE Comparison

Compare ARDX & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • NFE
  • Stock Information
  • Founded
  • ARDX 2007
  • NFE 2014
  • Country
  • ARDX United States
  • NFE United States
  • Employees
  • ARDX N/A
  • NFE N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • NFE Oil/Gas Transmission
  • Sector
  • ARDX Health Care
  • NFE Utilities
  • Exchange
  • ARDX Nasdaq
  • NFE Nasdaq
  • Market Cap
  • ARDX 882.9M
  • NFE 981.6M
  • IPO Year
  • ARDX 2014
  • NFE 2019
  • Fundamental
  • Price
  • ARDX $4.29
  • NFE $3.78
  • Analyst Decision
  • ARDX Strong Buy
  • NFE Buy
  • Analyst Count
  • ARDX 9
  • NFE 7
  • Target Price
  • ARDX $10.17
  • NFE $12.79
  • AVG Volume (30 Days)
  • ARDX 4.3M
  • NFE 13.2M
  • Earning Date
  • ARDX 08-04-2025
  • NFE 08-08-2025
  • Dividend Yield
  • ARDX N/A
  • NFE N/A
  • EPS Growth
  • ARDX N/A
  • NFE N/A
  • EPS
  • ARDX N/A
  • NFE N/A
  • Revenue
  • ARDX $361,706,000.00
  • NFE $2,127,808,000.00
  • Revenue This Year
  • ARDX $11.39
  • NFE $9.21
  • Revenue Next Year
  • ARDX $32.84
  • NFE $12.64
  • P/E Ratio
  • ARDX N/A
  • NFE N/A
  • Revenue Growth
  • ARDX 127.33
  • NFE N/A
  • 52 Week Low
  • ARDX $3.21
  • NFE $2.01
  • 52 Week High
  • ARDX $7.18
  • NFE $20.91
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 51.49
  • NFE 50.58
  • Support Level
  • ARDX $4.27
  • NFE $3.59
  • Resistance Level
  • ARDX $4.48
  • NFE $4.91
  • Average True Range (ATR)
  • ARDX 0.19
  • NFE 0.53
  • MACD
  • ARDX -0.03
  • NFE 0.00
  • Stochastic Oscillator
  • ARDX 15.84
  • NFE 39.64

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.

Share on Social Networks: